share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股SEC公告 ·  06/03 13:41
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer, Tatsis Ourania, is set to sell 2,175 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,000,500. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate occasions, with 740 shares acquired on 02/17/2024 and an additional 1,435 shares on 02/20/2024, both from the issuer. This planned sale follows a recent transaction history where a total of 4,600 shares were sold over the past three months, generating gross proceeds of $2,033,158.5.
Vertex Pharmaceuticals Inc. officer, Tatsis Ourania, is set to sell 2,175 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,000,500. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate occasions, with 740 shares acquired on 02/17/2024 and an additional 1,435 shares on 02/20/2024, both from the issuer. This planned sale follows a recent transaction history where a total of 4,600 shares were sold over the past three months, generating gross proceeds of $2,033,158.5.
Vertex Pharmaceuticals股票的官员Tatsis Ourania打算于2024年06月03日出售2175股普通股,市场总价值约为1000500美元。这些股份是作为两次受限股票兑现的一部分获得的,740股份于2024年02月17日获得,另外1435股份于2024年02月20日从发行人处获得。这个计划中的交易是在过去三个月中销售了4600股,总共获得了2033158.5美元的成交额。
Vertex Pharmaceuticals股票的官员Tatsis Ourania打算于2024年06月03日出售2175股普通股,市场总价值约为1000500美元。这些股份是作为两次受限股票兑现的一部分获得的,740股份于2024年02月17日获得,另外1435股份于2024年02月20日从发行人处获得。这个计划中的交易是在过去三个月中销售了4600股,总共获得了2033158.5美元的成交额。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息